Mona Al-Gizawiy

508 total citations
18 papers, 385 citations indexed

About

Mona Al-Gizawiy is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Mona Al-Gizawiy has authored 18 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Mona Al-Gizawiy's work include Glioma Diagnosis and Treatment (9 papers), Cancer, Hypoxia, and Metabolism (4 papers) and MicroRNA in disease regulation (4 papers). Mona Al-Gizawiy is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Cancer, Hypoxia, and Metabolism (4 papers) and MicroRNA in disease regulation (4 papers). Mona Al-Gizawiy collaborates with scholars based in United States, South Korea and Syria. Mona Al-Gizawiy's co-authors include Kathleen M. Schmainda, Christopher R. Chitambar, Wade M. Mueller, Jennifer Connelly, Shama P. Mirza, Scott D. Rand, Elizabeth J. Cochran, Ninh Doan, John S. Kuo and Ha Son Nguyen and has published in prestigious journals such as Oncotarget, Molecular Cancer Therapeutics and Breast Cancer Research and Treatment.

In The Last Decade

Mona Al-Gizawiy

18 papers receiving 379 citations

Peers

Mona Al-Gizawiy

GENET

ONCOL

RNMI

Xiaoqing Li China

Célia Pinheiro Portugal

Lu Kong China

Brian R. Vuillemenot United States

Katharina Koch Germany

Yuan Chang-ji China

Gabriel Arismendi-Morillo Venezuela

James Pilling United Kingdom

Nadimpalli Ravi S. Varma United States

Ron Batash Israel

Xiaoqing Li China

Mona Al-Gizawiy

154 ×0.8

34 ×0.4

GENET

54 ×0.7

72 ×1.2

ONCOL

9 ×0.2

RNMI

Citations per year, relative to Mona Al-Gizawiy Mona Al-Gizawiy (= 1×) peers Xiaoqing Li

Countries citing papers authored by Mona Al-Gizawiy

Since Specialization

Citations

This map shows the geographic impact of Mona Al-Gizawiy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Al-Gizawiy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Al-Gizawiy more than expected).

Fields of papers citing papers by Mona Al-Gizawiy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Al-Gizawiy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Al-Gizawiy. The network helps show where Mona Al-Gizawiy may publish in the future.

Co-authorship network of co-authors of Mona Al-Gizawiy

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Al-Gizawiy. A scholar is included among the top collaborators of Mona Al-Gizawiy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Al-Gizawiy. Mona Al-Gizawiy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Al-Gizawiy, Mona, Melissa Prah, Ninh Doan, et al.. (2024). Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma. Frontiers in Oncology. 13. 1278157–1278157. 4 indexed citations

Connelly, Jennifer, et al.. (2023). CTNI-57. PRELIMINARY RESULTS OF A PHASE 1 TRIAL OF ORAL GALLIUM MALTOLATE IN RECURRENT GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_5). v89–v89. 2 indexed citations

Prah, Melissa, Eun‐Jung Choi, Jongho Lee, et al.. (2022). Basal Ganglia Iron Content Increases with Glioma Severity Using Quantitative Susceptibility Mapping: A Potential Biomarker of Tumor Severity. Tomography. 8(2). 789–797. 5 indexed citations

Markley, John L., Jin Hae Kim, Mona Al-Gizawiy, et al.. (2020). The cytotoxicity of gallium maltolate in glioblastoma cells is enhanced by metformin through combined action on mitochondrial complex 1. Oncotarget. 11(17). 1531–1544. 8 indexed citations

Chitambar, Christopher R., Mona Al-Gizawiy, Kimberly R. Pechman, et al.. (2018). Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase. Molecular Cancer Therapeutics. 17(6). 1240–1250. 45 indexed citations

Nguyen, Ha Son, Saman Shabani, Mayank Kaushal, et al.. (2018). Irradiation of pediatric glioblastoma cells promotes radioresistance and enhances glioma malignancyviagenome-wide transcriptome changes. Oncotarget. 9(75). 34122–34131. 14 indexed citations

Doan, Ninh, Ha Son Nguyen, Mona Al-Gizawiy, et al.. (2018). Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model. Oncotarget. 9(34). 23532–23542. 19 indexed citations

Flister, Michael J., Shirng‐Wern Tsaih, Alexander J. Stoddard, et al.. (2017). Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer. Breast Cancer Research and Treatment. 165(1). 53–64. 15 indexed citations

Prah, Melissa, Mona Al-Gizawiy, Wade M. Mueller, et al.. (2017). Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics. Journal of Neuro-Oncology. 136(1). 13–21. 32 indexed citations

10.

Doan, Ninh, Ha Son Nguyen, Mona Al-Gizawiy, et al.. (2017). Acid ceramidase confers radioresistance to glioblastoma cells. Oncology Reports. 38(4). 1932–1940. 41 indexed citations

11.

Doan, Ninh, Mona Al-Gizawiy, Wade M. Mueller, et al.. (2017). Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency. Oncotarget. 8(68). 112662–112674. 56 indexed citations

12.

Al-Gizawiy, Mona, et al.. (2017). EXTH-40. TUMOR IRON STATUS SENSITIZES GLIOBLASTOMA CELLS TO THE CYTOTOXICITY OF AN INHIBITOR OF THE IRON-DEPENDENT M2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE. Neuro-Oncology. 19(suppl_6). vi81–vi81. 1 indexed citations

13.

Al-Gizawiy, Mona, Ninh Doan, Jeffrey Knipstein, et al.. (2017). TMOD-08. IN VITRO PRE-TREATMENT OF CELL LINES PRODUCES A ROBUST IN VIVO XENOGRAFT MODEL MIMICKING RECURRENT GLIOBLASTOMA. Neuro-Oncology. 19(suppl_6). vi256–vi256. 1 indexed citations

14.

Doan, Ninh, Ha Son Nguyen, Mona Al-Gizawiy, et al.. (2017). Acid ceramidase is a novel drug target for pediatric brain tumors. Oncotarget. 8(15). 24753–24761. 29 indexed citations

15.

Chesnik, Marla A., Brian Halligan, Mona Al-Gizawiy, et al.. (2014). Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics. Physiological Genomics. 46(13). 467–481. 40 indexed citations

16.

Smeester, Branden A., et al.. (2013). The Effect of Electroacupuncture on Osteosarcoma Tumor Growth and Metastasis: Analysis of Different Treatment Regimens. Evidence-based Complementary and Alternative Medicine. 2013. 1–13. 15 indexed citations

17.

Smeester, Branden A., Mona Al-Gizawiy, & Alvin J. Beitz. (2012). Effects of Different Electroacupuncture Scheduling Regimens on Murine Bone Tumor-Induced Hyperalgesia: Sex Differences and Role of Inflammation. Evidence-based Complementary and Alternative Medicine. 2012. 1–16. 16 indexed citations

18.

Al-Gizawiy, Mona, et al.. (2004). Comparison of preoperative carprofen and postoperative butorphanol as postsurgical analgesics in cats undergoing ovariohysterectomy. Veterinary Anaesthesia and Analgesia. 31(3). 164–174. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact